We are pleased to announce that Albert La Spada, MD, PhD, Distinguished Professor in the School of Medicine and director of the UCI Institute for Neurotherapeutics, has been named the new associate dean of research development, effective February 1, 2021.
 |
| Albert La Spada, MD, PhD |
La Spada is a specialist in neurology, clinical genetics, clinical molecular genetics and clinical pathology, and will be supporting Geoff Abbott, PhD, vice dean of basic science research.
With this new role, he will also be partnering with executive leadership and staff in establishing new research development programs, and directing the research development team in planning, developing, and executing research strategies and initiatives.
La Spada will work to advance the reputation, success and outreach of the School of Medicine’s research enterprise, and build relationships internally and externally that will increase the school’s funding portfolio. He will also strive to create synergy between basic science and clinical research teams, as well as oversee metrics regarding faculty funding levels, research space allocations, shared equipment and other facilities/resources.
La Spada completed fellowships in both clinical genetics and neurogenetics at the University of Washington, where he joined the faculty of the School of Medicine and ascended to the rank of professor, before moving to UC San Diego to become the division head of genetics and serve as associate director of the UC San Diego Institute for Genomic Medicine.
He then became the founding director of the Duke Center for Neurodegeneration and Neurotherapeutics, holding the Lincoln Endowed Chair for Neurobiology, prior to joining the UCI faculty on June 1, 2020
La Spada received his medical degree from the University of Pennsylvania, and completed a residency in anatomic & clinical pathology at the University of Washington, where he also completed fellowships in both clinical genetics and neurogenetics.
Please join us in congratulating Dr. La Spada on this new role.
Sincerely,
|
